Anti-MMP2 antibody [EPR1184] - Low endotoxin, Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(26 Publications)
Rabbit Recombinant Monoclonal MMP2 antibody. Carrier free. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 26 publications.
View Alternative Names
CLG4A, MMP2, 72 kDa type IV collagenase, 72 kDa gelatinase, Gelatinase A, Matrix metalloproteinase-2, TBE-1, MMP-2
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-MMP2 antibody [EPR1184] - Low endotoxin, Azide free (AB215986)
Intracellular Flow Cytometry analysis of PC-3 (human prostate adenocarcinoma) cells labeling MMP2 with purified ab92536 at 1/180 dilution (10ug/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluor® 488) (1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) were used as the unlabeled control.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab92536).
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-MMP2 antibody [EPR1184] - Low endotoxin, Azide free (AB215986)
Overlay histogram showing HeLa cells fixed in 4% PFA and stained with purified ab92536 at a dilution of 1 in 400 (red line). The secondary antibody used was FITC goat anti-rabbit at a dilution of 1 in 500. Rabbit monoclonal IgG was used as an isotype control (black line) and cells incubated in the absence of both primary and secondary antibody were used as a negative control (blue line). This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab92536).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-MMP2 antibody [EPR1184] - Low endotoxin, Azide free (AB215986)
Immunofluorescence staining of PC-3 cells with purified ab92536 at a working dilution of 1/250 counter-stained with DAPI. The secondary antibody was Alexa Fluor® 488 goat anti-rabbit (ab150077) used at a dilution of 1/1000. ab7291 a mouse anti-tubulin antibody (1/1000) was used to stain tubulin along with ab150120 (Alexa Fluor® 594 goat anti-mouse 1/1000) shown in the top right hand panel. The cells were fixed in 4% PFA and permeabilized using 0.1% Triton X 100. The negative controls are shown in bottom middle and right hand panels - for negative control 1 purified ab92536 was used at a dilution of 1/500 followed by an Alexa Fluor® 594 goat anti-mouse antibody (ab150120) at a dilution of 1/500. For negative control 2 ab7291 (mouse anti-tubulin) was used at a dilution of 1/500 followed by an Alexa Fluor® 488 goat anti-rabbit antibody (ab150077) at a dilution of 1/400.
This data was developed using the same antibody clone in a different buffer formulation containing PBS BSA glycerol and sodium azide (ab92536).
- WB
Lab
Western blot - Anti-MMP2 antibody [EPR1184] - Low endotoxin, Azide free (AB215986)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab92536). Blocking and diluting buffer and concentration : 5% NFDM /TBST. ab181602 was used as GAPDH loading control. Compared with ab92536, ab181286 has higher sensitivity. We recommend ab181286 as an alternative for testing MMP2 in western blot.
Lanes 1 - 5:
Western blot - Anti-MMP2 antibody [EPR1184] (<a href='/en-us/products/primary-antibodies/mmp2-antibody-epr1184-ab92536'>ab92536</a>) at 1/1000 dilution
Lanes 1 - 5:
Western blot - Anti-MMP2 antibody [EPR17003-25] (<a href='/en-us/products/primary-antibodies/mmp2-antibody-epr17003-25-ab181286'>ab181286</a>)
Lane 1:
HT-1080 (Human fibrosarcoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
Untreated HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
HepG2 (Human hepatocellular carcinoma epithelial cell) treated with 300ng/ml BFA for 24 hours whole cell lysate at 20 µg
Lane 4:
Huh7 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 5:
U-87 MG (Human glioblastoma-astrocytoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 73 kDa
false
Exposure time: 60s
- WB
Lab
Western blot - Anti-MMP2 antibody [EPR1184] - Low endotoxin, Azide free (AB215986)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab92536). Blocking and diluting buffer and concentration : 5% NFDM/TBST. ab181602 was used as a GAPDH loading control. Compared with ab92536, ab181286 has higher sensitivity. We recommend ab181286 as an alternative for testing MMP2 in western blot.
Lanes 1 - 3:
Western blot - Anti-MMP2 antibody [EPR1184] (<a href='/en-us/products/primary-antibodies/mmp2-antibody-epr1184-ab92536'>ab92536</a>) at 1/1000 dilution
Lanes 1 - 3:
Western blot - Anti-MMP2 antibody [EPR17003-25] (<a href='/en-us/products/primary-antibodies/mmp2-antibody-epr17003-25-ab181286'>ab181286</a>)
Lane 1:
Human plasma tissue lysate at 20 µg
Lane 2:
Human brain tissue lysate at 20 µg
Lane 3:
Human breast tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 73 kDa
Observed band size: 69 kDa,72 kDa
false
Exposure time: 60s
Related conjugates and formulations (9)
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-MMP2 antibody [EPR1184]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-MMP2 antibody [EPR1184]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-MMP2 antibody [EPR1184]
-
Anti-MMP2 antibody [EPR1184]
-
Anti-MMP2 antibody [EPR1184] - BSA and Azide free
-
660 APC
APC Anti-MMP2 antibody [EPR1184]
-
578 PE
PE Anti-MMP2 antibody [EPR1184]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-MMP2 antibody [EPR1184]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-MMP2 antibody [EPR1184]
Reactivity data
Product details
ab215986 is the carrier-free version of ab92536.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
What does low endotoxin mean?
Our low endotoxin, azide-free formats have low endotoxin level (1 EU/mg, determined by the TAL assay) and are free from azide, to achieve consistent experimental results in functional assays.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Matrix metalloproteinase-2 is mainly involved in the degradation of type IV and V collagens gelatin and fibronectin. As part of the metalloproteinase family it works alongside other MMPs to maintain tissue homeostasis and repair. MMP-2 forms part of a complex network that ensures the timely degradation of matrix components balancing synthesis and breakdown. It remains regulated by tissue inhibitors of metalloproteinases (TIMPs) preventing excessive degradation that could lead to tissue damage.
Pathways
MMP-2 plays a significant role within the extracellular matrix (ECM) remodeling and angiogenesis pathways. It interacts with various proteins including integrins and TIMP-2 to modulate cellular behaviors such as migration and invasion. MMP-2 contributes to processes like wound healing and embryonic development through its involvement in ECM degradation and new tissue formation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (26)
Recent publications for all applications. Explore the full list and refine your search
Bioengineered 13:12115-12126 PubMed35546072
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 25: PubMed35506437
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:2673-2685 PubMed35043728
2022
Applications
Unspecified application
Species
Unspecified reactive species
Aging 13:11665-11677 PubMed33879635
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 23: PubMed33786635
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 21:402 PubMed33717261
2021
Applications
Unspecified application
Species
Unspecified reactive species
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 278:3363-3374 PubMed33479848
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 23: PubMed33200797
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 11:596 PubMed32732916
2020
Applications
Unspecified application
Species
Unspecified reactive species
Neurochemical research 45:2398-2408 PubMed32728986
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com